Home Outcomes in pregnant patients with congenital heart disease by rurality
Article Open Access

Outcomes in pregnant patients with congenital heart disease by rurality

  • Mehr Jain ORCID logo EMAIL logo , Franklin Iheanacho , Kristen Sparagna , Shimon Shaykevich , Camilo E. Jaimes Cobos , Fernando Baraona Reyes , Michael H. Dahan and Maria A. Pabon
Published/Copyright: August 5, 2025

Abstract

Objectives

To examine the association between rurality, major adverse cardiac events (MACE), adverse pregnancy outcomes (APO) and neonatal outcomes in pregnant women with CHD (congenital heart disease).

Methods

A retrospective cohort study using the HCUP-NIS database (Healthcare Cost and Utilization Project-National Inpatient Sample) from 2016 to 2021 was conducted with pregnant CHD patients by location of residence (urban vs. rural). Primary outcomes were MACE, APO and neonatal outcomes. Multivariate logistic regression with survey procedures and weighted odds ratios was used to represent national estimates.

Results

The weighted sample represented 24,295 (n=4,859) patients, of which 20,840 (n=4168) were in urban setting and 3,455 (n=691) lived rurally. Only 27 % (n=185/691) of rural patients accessed care at a rural hospital. Rurality was associated with lower odds of APO (adjusted-OR 0.76; 95 %-CI 0.63–0.91; p=0.003). Rural patients with complex CHD had the lowest odds of APO. There was no statistically significant difference, by rurality, in odds of MACE (adjusted-OR 1.17; 95 %-CI 0.98–1.40; p=0.09) or neonatal outcomes (adjusted-OR 0.78; 95 %-CI 0.59–1.03; p=0.082). There was no effect modification of rurality by CHD complexity on the association between rurality and MACE (p-value=0.66), APO (p-value=0.60) or neonatal outcomes (p-value=0.75).

Conclusions

In this national cohort, pregnant patients with CHD living in rural areas had decreased odds of APO and no significant difference in MACE or neonatal complications. Notably, the majority of rural CHD patients received care in urban hospitals, suggesting referral patterns may mitigate outcome disparities. These findings highlight the need for further research on access, delivery of care, and outcomes for rural patients with CHD, and underscore the importance of ensuring multidisciplinary cardio-obstetric care across geographic settings.

Introduction

In recent decades, advances in the management of congenital heart disease (CHD) patients have significantly improved survival, enabling more women with CHD to reach reproductive age and pursue pregnancy [1]. Physiologic changes in pregnancy, such as increased cardiac output, expanded blood volume, and decrease in vascular resistance, may lead to increased risk of maternal and fetal complications in pregnant women with CHD [2]. As such, the AHA recommends that women with complex CHD must be cared for by an obstetrician and cardiologist with experience in the management of adult CHD [3].

These challenges in CHD patients may be amplified in rural areas. In general, rural patients have been shown to experience an increased risk for maternal mortality compared to their urban counterparts, a disparity largely driven by an increase in cardiovascular (CV) deaths [4], 5]. The increase in maternal mortality in rural areas may be related to access to specialized care, as the large majority of centers that specialize in providing care to at-risk adult patients are located in major cities. This is especially important for the CHD population, as studies have shown that care by an adult CHD program is associated with better clinical outcomes [6]. Given these complex disparities between rural and urban areas, the American Heart Association (AHA) released a call to action in 2020, to prioritize rural populations in programming, research, and policy [7]. The AHA recommended increasing specialist supply via telehealth, digitally enabled health care and regionalization of care to ensure all patients are treated adequately [7].

A recent study assessing pregnant patients in North Carolina with pre-existing cardiac disease showed no difference in severe maternal morbidity by rurality [8]. No studies have been done to identify outcomes in at a national level, and specifically for CHD patients based on rural status. Therefore, the primary aim of our study is to examine the association between patient location (urban or rural) and the development of major adverse cardiac events (MACE), adverse pregnancy outcomes (APO), and adverse neonatal outcomes in all pregnant women with CHD. The secondary aim of this study is to investigate the impact of patient setting on adverse cardiac, pregnancy, and neonatal outcomes in pregnant women with CHD by disease complexity.

Materials and methods

Study design and population

This is a retrospective population-based study, using the Healthcare Cost and Utilization Project-National Inpatient Sample (HCUP-NIS) database between 2016 and 2021. The HCUP-NIS is sponsored by the Agency for Healthcare Research and Quality and contains data about hospital utilization, outcomes, and costs at a national level. The HCUP-NIS is the largest inpatient database in the country and represents 96 % of the American population, with over 9 million admissions annually. The data is publicly available and anonymized. Hence, institutional review board approval was not required based on the guidelines of the Tri-Council Policy Statement (2018).

The NIS Core File was used to identify patient-level characteristics such as age at admission, median household income, primary insurance, and location of patient residence. For this analysis, we included hospitalized pregnant patients ≥18 years of age with a diagnosis of CHD during the study period. CHD was stratified by disease complexity based on the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease [3]. The list of ICD-10 codes included, stratified by disease complexity (complex, moderate and simple complexity) is shown in Supplementary Table S1. Patients who had a diagnosis of abortion or ectopic pregnancy or who were missing data on rural or urban residence were excluded. As per data available in HCUP-NIS, rural residence was defined as living in micropolitan counties with populations between 10,000 and 50,000 or in areas that are neither micropolitan nor metropolitan, based on the U.S. Department of Health and Human Services definition. All other patients were considered to reside in urban settings [9]. The rurality of the hospital at which care was accessed was abstracted separately.

Study outcomes

The primary outcomes for our study were three distinct measures: (1) major adverse cardiovascular events (MACE), (2) adverse pregnancy outcomes (APO), and (3) neonatal outcomes. MACE was defined as the occurrence of any event associated with an ICD-10 code for acute heart failure, arrhythmia, cerebrovascular accident, embolic events (cerebrovascular, pulmonary embolism), and unspecified cardiovascular complications of pregnancy and hospital death. APO was defined as the occurrence of any event with an ICD-10 code associated with gestational hypertension, preeclampsia, placental complications (including antepartum bleeding), fetal complications, preterm delivery, anesthetic complications, postpartum hemorrhage, complication with amniotic fluid, gestational diabetes, liver disorder in pregnancy, or antepartum/postpartum infection. Neonatal outcomes were defined as the occurrence of any event with an ICD-10 code associated with small for gestational age, intrauterine fetal demise, neonatal birth trauma, and congenital disorder. The complete list of ICD-10 codes can be found in Supplementary Table 1.

Statistical analysis

Descriptive statistics for the study population by rurality status were compared using counts and percentages for categorical variables, means and standard deviations for normally distributed continuous variables, and medians and interquartile ranges for non-normally distributed continuous variables. To compare differences between groups, Pearson’s χ2 tests, two-sample t-tests, and Wilcoxon rank-sum tests were used, respectively.

Univariate logistic regression was applied to determine the odds of MACE, APOs, and neonatal outcomes by rurality. Multivariable logistic regression was applied to determine odds of MACE, APOs, and neonatal outcomes by rurality adjusting for age, race, income, insurance payer, smoking, alcohol use, drug use in pregnancy, diabetes, obesity, pulmonary disease, liver disease and uterine fibroids [10]. Each regression was stratified by CHD complexity, and a sensitivity analysis was conducted to where moderate and complex CHD were grouped together due to the small sample size in each of these two complexity categories. A univariate analysis was conducted to assess the interaction term between rurality and MACE, rurality and APO, as well as rurality and neonatal outcomes.

All analyses used survey procedures and SAS 9.4 to account for the complex design of HCUP-NIS database. All proportions and odds ratios were weighted to reflect national estimates. two-sided p values of <0.05 were considered statistically significant.

Results

Baseline characteristics

A total of 4859 patients met inclusion criteria, representing 24,295 patients nationally. Of those, 691 patients (14 %, n=3455 patients represented nationally) were rural residents. Compared to patients residing in urban settings, residents of rural areas were slightly younger (27.1 vs. 29.5 years old, p<0.001), more likely to be of White race (84.1 % vs. 62.3 %, p<0.001), and tended to have lower income and public insurance. There was no difference in the rates of vaginal or c-section deliveries between rural and urban areas (vaginal delivery 45 % vs. 46 %, p=0.75 and, c-section 33% vs. 32 %, p=0.53, for those residing in rural vs. urban areas respectively). Of note, the database was missing information on mode of delivery for 22 % of deliveries. Of the patients who accessed care at an urban hospital, 85.4 % were living in an urban location while 10.4 % were from a rural location (Table 1). Of all patients living in a rural setting in this cohort, only 26.8 % (n=185/691) accessed care at a rural hospital.

Table 1:

Baseline characteristics of pregnant patients with congenital heart disease (CHD) by rurality status.

Urban Rural p-Value
Unweighted, n 4168 691
Weighted, n 20,840 3455
Age, years, mean (SD) 29.5 (0.09) 27.1 (0.20) <0.0001
Race, n (weighted %)
 White 2509 (62.3 %) 566 (84.1 %) <0.0001
 Black 517 (12.8 %) 34 (5.1 %) <0.0001
 Hispanic 663 (16.5 %) 37 (5.5 %) <0.0001
 Other 338 (8.4 %) 36 (5.4 %) 0.0094
Income
 $1–43,999 883 (21.3 %) 334 (49.4 %) <0.0001
 $44,000–55,999 930 (22.4 %) 253 (37.4 %) <0.0001
 $56,000–73,999 1211 (29.2 %) 74 (10.9 %) <0.0001
 >$74,000 1125 (27.1 %) 15 (2.2 %) <0.0001
Hospital location <0.0001
 Rural 17 (0.4 %) 185 (3.8 %)
 Urban 4151 (85.4 %) 506 (10.4 %)
Primary expected payer, n (weighted %)
 Public (medicare/medicaid) 1626 (39.0 %) 321 (46.5 %) 0.0002
 Private 2332 (55.9 %) 335 (48.5 %) 0.0003
 Other 207 (4.9 %) 35 (5.1 %) 0.92
AHA CHD complexity
 Simple 2260 (54.2 %) 332 (48.1 %) 0.003
 Moderate 1672 (40.1 %) 313 (45.3 %) 0.01
 Complex 236 (5.7 %) 46 (6.7 %) 0.29
Vaginal delivery 1922 (46.1 %) 314 (45.4 %) 0.75
Caesarean section 1343 (32.2 %) 231 (33.4 %) 0.53
Smoking 211 (5.1 %) 69 (9.9 %) <0.0001
Alcohol in pregnancy 9 (0.2 %) 0 (0 %)
Drug use in pregnancy 41 (0.9 %) 12 (1.7 %) 0.09
Diabetes 115 (2.8 %) 12 (1.7 %) 0.11
Chronic renal disease 30 (0.7 %) 4 (0.6 %) 0.68
Pulmonary disease 533 (12.8 %) 80 (11.6 %) 0.37
Liver disease 36 (0.9 %) 6 (0.9 %) 0.99
Obesity 459 (11.0 %) 82 (11.9 %) 0.47
Number of medical co-morbidities
 1 967 (23.2 %) 175 (25.3 %) 0.22
 2 187 (4.5 %) 36 (5.2 %) 0.38
 =>3 31 (0.7 %) 6 (0.9 %) 0.73
Gynecologic disorders
 Fibroids 83 (1.9 %) 5 (0.7 %) 0.02
 ≥1 Gynecologic diagnosis 150 (3.6 %) 12 (1.7 %) 0.01
MACE 1678 (40.3 %) 306 (44.3 %) 0.05
APO 2147 (51.5 %) 321 (46.5 %) 0.02
Neonatal outcomes 522 (12.5 %) 75 (10.9 %) 0.21
  1. SD, standard deviation; CHD, congenital heart disease; PID, pelvic inflammatory disease.

In terms of CHD complexity among rural patients, 48.1 % had simple CHD, while 54.2 % of urban patients were in this category (p=0.003). Similarly, 45.3 % of rural patients had moderate CHD complexity, compared to 40.1 % in urban areas (p=0.01). There was no significant difference between rural and urban patients in the prevalence of complex CHD (6.7% vs. 5.7 %, respectively, p=0.29). Patients with CHD residing in rural areas were more likely to have a history of smoking (9.9% vs. 5.1 %, p<0.001), but were less likely to have gynecologic disorders at baseline. Otherwise, chronic comorbidities were similar between the two groups (Table 1).

MACE

Rural patients tended to have a higher rate of MACE compared to urban patients, although this was not statistically significant (rural: 44.3 %, urban: 40.3 %, p=0.05) (Table 1). Similar results were seen after adjusting for relevant covariates (adjusted-OR 1.17; 95 %-CI 0.98–1.40; p=0.09) (Table 2, Figure 1). When stratified by complexity of CHD, no statistically significant difference in odds of MACE was observed (Pinteraction=0.66) (Table 2). In terms of specific adverse cardiac events, patients residing in rural areas were more likely to be diagnosed with atrial arrhythmias (adjusted-OR 1.26; 95 %-CI 1.05–1.52; p=0.01), but otherwise, there were no other significant differences between groups (Table 3). Among rural residents with CHD, those that accessed care at a rural hospital had lower odds of MACE (adjusted-OR 0.54; 95 %-CI 0.38–0.79; p=0.001); however, nearly half (47 %) of those receiving care at rural hospitals had simple CHD, suggesting a potential referral bias of more complex cases to urban centers (Table 4).

Table 2:

Odds of major cardiovascular event, adverse pregnancy outcomes, and neonatal outcomes, by CHD complexity and rurality status.

Outcomes overall and by complexity Urban

n
Rural

n
Crude OR (95 % CI) p-value Adjusteda OR (95 % CI) p-value
Major adverse cardiovascular events (MACE)
 Overall 1678 (40.3 %) 306 (44.3 %) 1.18 (0.99–1.39), p=0.05 1.17 (0.97–1.39), p=0.08
 Simple CHD 820 (48.9 %) 133 (43.5 %) 1.17 (0.92–1.49), p=0.20 1.17 (0.90–1.52), p=0.24
 Moderate CHD 758 (45.2 %) 154 (50.3 %) 1.168 (0.92–1.48), p=0.20 1.18 (0.90–1.53), p=0.23
 Complex CHD 100 (5.9 %) 19 (6.2 %) 0.96 (0.54–1.71), p=0.88 0.89 (0.43–1.84), p=0.76
Adverse pregnancy outcomes (APO)
 Overall 2147 (51.5 %) 321 (46.5 %) 0.82 (0.69–0.97), p=0.018 0.76 (0.63–0.91), p=0.003
 Simple CHD 1128 (52.5 %) 141 (43.9 %) 0.741 (0.59–0.94), p=0.012 0.70 (0.54–0.91), p=0.008
 Moderate CHD 862 (40.2 %) 155 (48.3 %) 0.92 (0.73–1.16), p=0.49 0.80 (0.62–1.04), p=0.09
 Complex CHD 157 (7.3 %) 25 (7.8 %) 0.59 (0.33–1.09), p=0.09 0.63 (0.31–1.28), p=0.20
Neonatal outcomes
 Overall 522 (12.5 %) 75 (10.9 %) 0.85 (0.66–1.09), p=0.21 0.78 (0.59–1.03), p=0.08
 Simple CHD 238 (10.5 %) 27 (8.1 %) 0.75 (0.50–1.13), p=0.17 0.66 (0.43–1.02), p=0.06
 Moderate CHD 207 (12.4 %) 40 (12.8 %) 1.04 (0.73–1.48), p=0.84 0.95 (0.64–1.42), p=0.80
 Complex CHD 77 (32.6 %) 8 (17.4 %) 0.44 (0.22–0.87), p=0.018 0.58 (0.25–1.34), p=0.20
  1. Urban is referent group. OR, odds ratio; CI, confidence interval; CHD, congenital heart disease. aAdjusted for age, diabetes, alcohol use, drug use in pregnancy, smoking, obesity, pulmonary disease, liver disease, uterine fibroids, income, race, insurance payer.

Figure 1: 
Forest plot of odds of major cardiovascular event, adverse pregnancy outcomes, and neonatal outcomes. APO, adverse pregnancy outcomes; MACE, major adverse cardiovascular events.
Figure 1:

Forest plot of odds of major cardiovascular event, adverse pregnancy outcomes, and neonatal outcomes. APO, adverse pregnancy outcomes; MACE, major adverse cardiovascular events.

Table 3:

Odds of individual cardiovascular, pregnancy and neonatal outcomes, by rurality status.

Outcomes overall and by complexity Urban n Rural n Crude OR (95 % CI) p-value Adjusteda OR (95 % CI) p-value
Major adverse cardiovascular events (MACE) 1678 306 1.18 (0.99–1.39), p=0.05 1.17 (0.98–1.40), p=0.09
Acute myocardial infarction 17 (0.4 %) 2 (0.3 %) 0.71(0.16–3.07), p=0.65 0.48 (0.07–3.38), p=0.46
Acute heart failure 92 (2.2 %) 17 (2.5 %) 1.12 (0.65–1.92), p=0.69 0.83 (0.45–1.56), p=0.57
Pulmonary embolism 18 (0.4 %) 8 (1.2 %) 2.70 (1.18–6.18), p=0.02 2.28 (0.88–5.94), p=0.09
Cerebrovascular accident 77 (1.9 %) 13 (1.9 %) 1.02 (0.57–1.83), p=0.95 0.909 (0.48–1.72), p=0.77
Ventricular arrhythmias 47 (1.1 %) 4 (0.6 %) 0.51 (0.18–1.43), p=0.19 0.43 (0.15–1.23), p=0.12
Atrial arrhythmias 1445 (34.7 %) 272 (39.4 %) 1.22 (1.03–1.45), p=0.019 1.26 (1.05–1.51), p=0.014
Cardiac arrest 6 (0.1 %) 2 (0.3 %) 2.01 (0.41–9.99), p=0.39 4.53 (0.75–27.36), p=0.09
Other vascular complication related to pregnancy 146 (3.5 %) 29 (4.2 %) 1.21 (0.81–1.79), p=0.35 1.08 (0.69–1.68), p=0.74
Adverse pregnancy outcomes (APO) 2147 321 0.82 (0.69–0.97), p=0.018 0.755 (0.63–0.91), p=0.003
Gestational HTN 728 (17.5 %) 115 (16.6 %) 0.94 (0.76–1.17), p=0.59 0.86 (0.68–1.09), p=0.22
Placenta disorders 204 (4.9 %) 32 (4.6 %) 0.94 (0.64–1.39), p=0.77 1.05 (0.69–1.59), p=0.84
Fetal complications 722 (17.3 %) 100 (14.5 %) 0.81 (0.65–1.01), p=0.06 0.75 (0.59–0.96), p=0.02
Preterm birth 247 (5.9 %) 41 (5.9 %) 1.00 (0.69–1.45), p=0.99 0.84 (0.56–1.26), p=0.40
Anesthesia complications 21 (0.5 %) 1 (0.1 %) 0.29 (0.04–2.16), p=0.223 0.19 (0.02–1.59), p=0.13
Postpartum hemorrhage 276 (6.6 %) 45 (6.5 %) 0.98 (0.71–1.36), p=0.91 1.09 (0.78–1.54), p=0.60
Amniotic fluid 205 (4.9 %) 23 (3.3 %) 0.67 (0.43–1.03), p=0.07 0.74 (0.47–1.17), p=0.20
Gestational diabetes 339 (8.1 %) 56 (8.1 %) 0.99 (0.74–1.34), p=0.98 1.29 (0.92–1.81), p=0.15
Liver disorders 89 (2.1 %) 16 (2.3 %) 1.09 (0.64–1.85), p=0.76 0.95 (0.52–1.75), p=0.88
Infection 306 (7.3 %) 34 (4.9 %) 0.65 (0.45–0.95), p=0.02 0.58 (0.39–0.86), p=0.006
Neonatal outcomes 522 (12.5 %) 75 (10.9 %) 0.85 (0.66–1.09), p=0.21 0.78 (0.59–1.03), p=0.08
SGA 291 (6.9 %) 40 (5.8 %) 0.82 (0.58–1.15), p=0.25 0.76 (0.53–1.11), p=0.15
IUFD 31 (0.7 %) 4 (0.6 %) 0.78 (0.27–2.22), p=0.64 0.60 (0.19–1.89), p=0.39
Congenital disorders 262 (6.3 %) 37 (5.4 %) 0.84 (0.60–1.20), p=0.34 0.76 (0.52–1.12), p=0.17
  1. Urban is referent group. OR, odds ratio; CI, confidence interval; HTN, hypertension; SGA, small gestational age; IUFD, intrauterine fetal demise. aAdjusted for age, diabetes, alcohol use, drug use in pregnancy, smoking, obesity, pulmonary disease, liver disease, uterine fibroids, income, race, insurance payer.

Table 4:

Odds of major cardiovascular event, adverse pregnancy outcomes, and neonatal outcomes, by CHD complexity and rural status of hospital, among patients living in rural areas.

Outcomes overall and by complexity Urban hospital Rural hospital Crude OR (95 % CI) p-value Adjusteda OR (95 % CI) p-value
Major adverse cardiovascular events (MACE) 224 (48.2 %) 62 (33.5 %) 0.54 (0.38–0.78), p=0.0008 0.54 (0.38–0.79), p=0.001
Adverse pregnancy outcomes (APO) 252 (49.8 %) 69 (37.3 %) 0.60 (0.42–0.85), p=0.0047 0.57 (0.39–0.83), p=0.003
Neonatal outcomes 65 (12.9 %) 10 (5.4 %) 0.39 (0.20–0.77), p=0.006 0.31 (0.14–0.67), p=0.003
  1. Urban is referent group. OR, odds ratio; CI, confidence interval. aAdjusted for age, number of medical comorbidities, uterine fibroids, income, race, insurance payer.

APO

Rural patients had lower rate of APO compared to urban patients (rural: 46.5 %, urban: 51.5 %, p=0.02) (Table 1). These findings were consistent after adjusting for relevant covariates (adjusted-OR 0.76; 95 %-CI 0.63–0.91; p=0.003) (Table 2, Figure 1) and remained consistent in a sensitivity analysis restricted to rural residents comparing outcomes by hospital location (Table 4). When stratified by CHD complexity, rural patients with simple disease had lower odds of APO (adjusted OR 0.70, 95 % CI 0.54–0.91, p=0.008), whereas this association was not statistically significant in patients with moderate or complex CHD (Table 2). However, there was no significant effect modification by CHD complexity (Pinteraction=0.60). Regarding specific APOs, compared to patients residing in urban settings, residents of rural areas were less likely to have infection complications (adjusted-OR 0.58; 95 %-CI 0.40–0.86; p=0.006) (Table 3).

Neonatal outcomes

There was no difference in adverse neonatal outcomes between CHD patients residing in rural compared to urban areas (10.9 % and 12.5 %, respectively, p=0.25) (Table 1). Similar results were observed after adjusting for relevant covariates (adjusted-OR 0.78; 95 %-CI 0.59–1.03; p=0.082) (Table 2, Figure 1). There was no evidence of effect modification by CHD complexity (Pinteraction=0.75) and no difference in specific adverse neonatal outcomes by rurality (Table 3). However, in a sensitivity analysis restricted to rural residents, those who accessed care at a rural hospital had lower odds of adverse neonatal outcomes (adjusted-OR 0.31; 95 %-CI 0.14–0.67; p=0.003; Table 4).

Sensitivity analysis

A sensitivity analysis in which moderate and complex CHD was grouped together also showed no statistically significant difference in odds of MACE, APO and neonatal outcomes amongst these patients. The adjusted odds of MACE in patients with either moderate or complex CHD was 1.148 (95 %-Cl 0.894–1.473; p=0.28). The adjusted odds of APO in patients with either moderate or complex CHD was 0.782 (95 %-Cl 0.610–1.002; p=0.051). The adjusted odds of neonatal in patients with either moderate or complex CHD was 0.854 (95 %-Cl 0.591–1.235; p=0.40).

Discussion

In this retrospective population-based analysis using data from the HCUP-NIS, we compared cardiovascular and pregnancy outcomes in pregnant women with CHD based on their rurality status. Our key findings were: 1) the majority of pregnant women with CHD reside in urban areas; 2) the majority of CHD patients who live in rural areas received care in urban areas; 3) there was no difference in the risk of MACE or adverse neonatal outcomes in patients with CHD residing in rural areas vs. those in urban areas; and 4) compared to residents of urban areas, those residing in rural areas had 24 % lower odds of APO.

Even though there are approximately 28 million women of reproductive age who live in rural areas [5], the availability of hospital-based obstetric services has significantly declined over the past decade [11]. This decline has been linked to reduced access to prenatal care, which can exacerbate maternal and fetal risks during pregnancy [11]. Furthermore, certain risk factors, such as smoking, obesity, and substance use, are disproportionately prevalent among women living in rural areas [12], 13]. Consequently, prior studies have shown that women residing in rural areas experience higher rates of severe maternal and neonatal morbidity [11], [12], [13], [14], likely reflecting disparities in healthcare access, quality of care, and socioeconomic factors.

Interestingly, rural residents in our study had a lower risk of APO. In our cohort, women in rural areas did not differ significantly in comorbidities compared to urban residents, except for a higher rate of smoking. In addition, most women with CHD from rural areas received care in urban hospitals. This lower risk of APO may be attributed to two factors: access to urban-based care for rural residents and the comparable comorbidity profile between rural and urban groups (other than smoking and gynecologic disorders), potentially explaining why our findings differ from those of previous studies. Conversely, there was no difference in MACE or adverse neonatal outcomes in rural CHD patients compared to those residing in urban areas. Even when rural patients access urban hospitals for obstetrical and cardiac care, they may lack equivalent access to multidisciplinary care that is easily accessible to an urban patient. Another difference between cardiac and obstetrical care is the opportunity to have a proactive approach when early signs of obstetrical complications (ex. gestational hypertension prior to progression to preeclampsia) which can lead to a proactive approach such as a planned delivery at an urban center. Cardiac events may be less predictable and present less opportunity for risk mitigation.

These results may also be confounded by the fact that rural CHD women who receive care in rural settings may be referred to higher-volume rural hospitals, which generally have better outcomes than lower-volume facilities [15]. In our cohort, only 26.8 % of rural patients accessed care at a rural hospital. Obstetrical patients with cardiac disease require complex care for delivery which may only logistically be available at an urban centre. However rural patients may have higher odds of MACE, indicating that there is a strong need for cardiac programs in rural settings, with collaboration with urban tertiary centres, to improve access to care for pregnant patients with CHD.

Cardiovascular disease remains the leading cause of maternal mortality in the U.S., accounting for a significant portion of maternal deaths [12], 16], 17]. Women with CHD, in particular, face a markedly higher risk of maternal morbidity and mortality compared to their counterparts without CHD [18], [19], [20]. A prior study using the HCUP-NIS showed that the odds for cardiovascular and obstetric complications among delivery hospitalizations were 10.5–35.5 and 1.2–2.1 times higher for women with CHD compared with those without CHD [21]. Importantly, previous studies have demonstrated that the risk of CV complications tends to increase with CHD complexity, and the variation in outcomes based on the type and severity of CHD has been shown [14], 19], 22]. As maternal CHD complexity increases, so does the need for specialized care and comprehensive management during pregnancy. Our study did not find effect modification by CHD complexity across any of the outcomes (ie. MACE, APO or neonatal outcomes). However, our study is likely underpowered to detect effect modification by complexity of CHD.

Prior studies have shown that despite declining mortality in patients with CHD in urban counties, rural counties continue to experience persistently higher mortality rates [22]. However, to our knowledge, this is the first study to specifically examine the impact of rurality on maternal outcomes in women with CHD. The observed trend towards a higher risk of MACE in women with CHD residing in rural areas aligns with existing knowledge about the challenges faced by rural populations. Nevertheless, the lack of statistical significance may be attributed to limited statistical power, as CHD remains a relatively rare diagnosis, and only 14 % of our study population was a rural resident, and among those, only 7 % had complex CHD. Future studies with larger populations are warranted to further explore the true effect of rurality on MACE in this high-risk population.

Strengths and limitations

The use of the HCUP-NIS database imposes certain constraints on our study. Its focus on inpatient care does not allow for the incorporation of outpatient settings, post-discharge complications or longitudinal data. The lack of detailed clinical information in the database may lead to challenges in controlling for confounding variables, potentially affecting the validity of the conclusions drawn from the analysis. Limitations in the clinical information available in the database such as lack of granular anatomic and physiological details, also prevent the use of other cardiac risk categories (such as mWHO or CARPREG) in the pregnant population. Additionally, the absence of information on patient outcomes or mortality post-discharge restricts our ability to investigate antenatally or post-partum outcomes. Also, the inability of the NIS to link maternal and infant records may limit the accuracy of capturing neonatal outcomes, although stillbirth is expected to be reliably coded on the maternal claim. Furthermore, ICD-10 diagnostic codes do not differentiate by disease severity or repaired status of congenital heart disease, and some of the patients may have been misclassified into the wrong complexity categories. Also, we are unable to stratify by state, assumption of independence of each datapoint may be questionable as we don’t have information on parity. The changes in coding practices and data collection over time may hinder the validity of trend analyses when using HCUP-NIS data across multiple years. Finally, dichotomizing rurality may not fully capture the complexity of the rural-urban spectrum. County-based measures of rurality, as used in this analysis, can be limited by the varying geographic sizes and distribution of infrastructure and resources across counties.

Conclusions

In conclusion, rural CHD patients in our cohort had reduced odds of APO compared to those residing in urban areas, but there was no difference in terms of MACE or adverse neonatal outcomes, which may be attributed to a comparable comorbidity profile between rural and urban patients and the fact that rural CHD patients were almost three times more likely to seek care at an urban hospital than a rural one.


Corresponding author: Mehr Jain, MD, Department of Obstetrics and Gynecology, The Ottawa Hospital, Ottawa, Canada; and Harvard T.H. Chan School of Public Health, Boston, MA, USA, E-mail:
Michael H. Dahan and Maria A. Pabon contributed equally to this work and share senior authorship.

Funding source: 2024 OBGYN Resident Research Grant (funding agency: Department of Obstetrics, Gynaecology and Newborn Care, The Ottawa Hospital)

Award Identifier / Grant number: N/A

  1. Research ethics: Not applicable.

  2. Informed consent: Not applicable.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission. Mehr Jain – Project development, data analysis, manuscript writing. Franklin Iheanacho – Project development, data analysis, manuscript writing. Kristen Sparagna – Project development, data analysis, manuscript editing. Shimon Shaykevich – data analysis, manuscript editing. Camilo E. Jaimes Cobos – Project development, data analysis, manuscript editing. Fernando Baraona Reyes – Data interpretation, manuscript editing. Michael H. Dahan – Project development, data interpretation, manuscript editing. Maria A Pabon – Project development, data interpretation, manuscript writing.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: 2024 OBGYN Resident Research Grant (MJ) (funding agency: Department of Obstetrics, Gynaecology and Newborn Care, The Ottawa Hospital; grant number: not applicable).

  7. Data availability: Not applicable. The study does not included raw data. Data analysis was completed with a public national database (HCUP-NIS database).

References

1. Lima, FV, Yang, J, Xu, J, Stergiopoulos, K. National trends and in-hospital outcomes in pregnant women with heart disease in the United States. Am J Cardiol 2017;119:1694–700. https://doi.org/10.1016/j.amjcard.2017.02.003.Search in Google Scholar PubMed

2. Karamlou, T, Diggs, BS, McCrindle, BW, Welke, KF. A growing problem: maternal death and peripartum complications are higher in women with grown-up congenital heart disease. Ann Thorac Surg 2011;92:2193–8. https://doi.org/10.1016/j.athoracsur.2011.05.088.Search in Google Scholar PubMed

3. Stout, KK, Daniels, CJ, Aboulhosn, JA, Bozkurt, B, Broberg, CS, Colman, JM, et al.. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: Executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019;73:1494–563. https://doi.org/10.1016/j.jacc.2018.08.1028.Search in Google Scholar PubMed

4. Kozhimannil, KB, Hung, P, Henning-Smith, C, Casey, MM, Prasad, S. Association between loss of hospital-based obstetric services and birth outcomes in rural counties in the United States. JAMA 2018;319:1239–47. https://doi.org/10.1001/jama.2018.1830.Search in Google Scholar PubMed PubMed Central

5. Tong, ST, Morgan, ZJ, Bazemore, AW, Eden, AR, Peterson, LE. Maternity access in rural America: the role of family physicians in providing access to cesarean sections. J Am Board Fam Med 2023;36:565–73. https://doi.org/10.3122/jabfm.2023.230020r1.Search in Google Scholar PubMed

6. Mylotte, D, Pilote, L, Ionescu-Ittu, R, Abrahamowicz, M, Khairy, P, Therrien, J, et al.. Specialized adult congenital heart disease care. Circulation [Internet]. 2014. [cited 2024]; Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.113.005817.10.1161/CIRCULATIONAHA.113.005817Search in Google Scholar PubMed

7. Call to Action. Rural health: a presidential advisory from the American Heart Association and American Stroke Association | Circulation [Internet]. [cited 2024]. Available from: https://www.ahajournals.org/doi/10.1161/cir.0000000000000753.Search in Google Scholar

8. Moyett, JM, Zambrano Guevara, LM, Mallampati, DP, Menard, MK, Hughes, BL, Small, MJ, et al.. Racial and rural-urban disparities in maternal cardiac disease care in North Carolina: a call to action. N C Med J 2023;84:249–56. https://doi.org/10.18043/001c.81277.Search in Google Scholar PubMed PubMed Central

9. How we define rural | HRSA [Internet]. [cited 2024 Dec 5]. Available from: https://www.hrsa.gov/rural-health/about-us/what-is-rural.Search in Google Scholar

10. Choudhary, A, Inamdar, SA, Sharma, U. Pregnancy with uterine fibroids: obstetric outcome at a tertiary care hospital of Central India. Cureus 2023;15:e35513. https://doi.org/10.7759/cureus.35513.Search in Google Scholar PubMed PubMed Central

11. Nighbor, TD, Doogan, NJ, Roberts, ME, Cepeda-Benito, A, Kurti, AN, Priest, JS, et al.. Smoking prevalence and trends among a U.S. national sample of women of reproductive age in rural versus urban settings. PLoS One 2018;13:e0207818. https://doi.org/10.1371/journal.pone.0207818.Search in Google Scholar PubMed PubMed Central

12. Higgins, JP, Higgins, JA. Epidemiology of peripheral arterial disease in women. J Epidemiol 2003;13:1–14. https://doi.org/10.2188/jea.13.1.Search in Google Scholar PubMed PubMed Central

13. Harrington, KA, Cameron, NA, Culler, K, Grobman, WA, Khan, SS. Rural-urban disparities in adverse maternal outcomes in the United States, 2016–2019. Am J Public Health 2023;113:224–7. https://doi.org/10.2105/ajph.2022.307134.Search in Google Scholar

14. Ramage, K, Grabowska, K, Silversides, C, Quan, H, Metcalfe, A. Association of adult congenital heart disease with pregnancy, maternal, and neonatal outcomes. JAMA Netw Open 2019;2:e193667. https://doi.org/10.1001/jamanetworkopen.2019.3667.Search in Google Scholar PubMed PubMed Central

15. Haiman, MD, Cubbin, C. Impact of geography and rurality on Preconception health status in the United States. Prev Chronic Dis [Internet] 2023;20. [cited 2024]Available from: https://www.cdc.gov/pcd/issues/2023/23_0104.htm.10.5888/pcd20.230104Search in Google Scholar PubMed PubMed Central

16. Higgins, ST, Erath, T, Chen, FF. Examining U.S. disparities in smoking among rural versus urban women of reproductive age: 2002-2019. Prev Med 2024;185:108054. https://doi.org/10.1016/j.ypmed.2024.108054.Search in Google Scholar PubMed PubMed Central

17. Schlichting, LE, Insaf, TZ, Zaidi, AN, Lui, GK, Van Zutphen, AR. Maternal comorbidities and complications of delivery in pregnant women with congenital heart disease. J Am Coll Cardiol 2019;73:2181–91. https://doi.org/10.1016/j.jacc.2019.01.069.Search in Google Scholar PubMed

18. Opotowsky, AR, Siddiqi, OK, D’Souza, B, Webb, GD, Fernandes, SM, Landzberg, MJ. Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart 2012;98:145–51. https://doi.org/10.1136/heartjnl-2011-300828.Search in Google Scholar PubMed

19. Drenthen, W, Boersma, E, Balci, A, Moons, P, Roos-Hesselink, JW, Mulder, BJM, et al.. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010;31:2124–32. https://doi.org/10.1093/eurheartj/ehq200.Search in Google Scholar PubMed

20. Thompson, JL, Kuklina, EV, Bateman, BT, Callaghan, WM, James, AH, Grotegut, CA. Medical and obstetric outcomes among pregnant women with congenital heart disease. Obstet Gynecol 2015;126:346–54. https://doi.org/10.1097/aog.0000000000000973.Search in Google Scholar

21. Hardee, I, Wright, L, McCracken, C, Lawson, E, Oster, ME. Maternal and neonatal outcomes of pregnancies in women with congenital heart disease: a meta-analysis. J Am Heart Assoc 2021;10:e017834. https://doi.org/10.1161/jaha.120.017834.Search in Google Scholar

22. Minhas, AMK, Wyand, RA, Ariss, RW, Nazir, S, Jain, V, Al-Kindi, SG, et al.. Rural-urban trends in congenital heart disease-related mortality in the United States, 1999 to 2019. JACC Adv 2022;1:100030. https://doi.org/10.1016/j.jacadv.2022.100030.Search in Google Scholar PubMed PubMed Central


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/jpm-2024-0627).


Received: 2024-12-30
Accepted: 2025-05-27
Published Online: 2025-08-05
Published in Print: 2025-09-25

© 2025 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Integrating NIPT and ultrasound for detecting fetal aneuploidies and abnormalities
  4. Ethical challenges in perinatal ultrasound: balancing diagnostic capability and ethical communication
  5. Original Articles – Obstetrics
  6. Risk factors and adverse outcomes associated with hepatitis C virus in pregnancy
  7. Utility of endometrial multi-vessel blood flow ultrasound parameters in predicting pregnancy outcomes
  8. Improving the accuracy of screening for large-for-gestational-age fetuses: a multicenter observational study
  9. Risk factors and awareness of tobacco smoking and second-hand smoke exposure among pregnant women in Taiwan
  10. Effect of oral hydration therapy on amniotic fluid index and maternal-neonatal outcomes in pregnant women with oligohydramnios: a systematic review and meta-analysis
  11. Epidural anesthesia during labor and delivery and postpartum hemorrhage
  12. Social vulnerability and triage acuity among pregnant people seeking unscheduled hospital care
  13. Gestational diabetes insipidus. A systematic review of case reports
  14. Outcomes in pregnant patients with congenital heart disease by rurality
  15. Original Articles – Fetus
  16. Exploration of copy number variations and candidate genes in fetal congenital heart disease using chromosomal microarray analysis
  17. A seven-year retrospective cohort study on non-immune foetal hydrops from a single centre in an LMIC setting
  18. Original Articles – Neonates
  19. Correlation between macronutrient content and donation characteristics in Croatian human milk bank
  20. Gestational diabetes mellitus: the role of IGF-1 and leptin in cord blood
Downloaded on 23.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2024-0627/html
Scroll to top button